CANF Stock Analysis: Buy, Sell, or Hold?
CANF - Can-Fite BioPharma Ltd. American Depositary Shares, each representing three hundred (300) Ordinary Shares
$3.91
-0.72 (-15.55%)
▼
5d:
+32.99%
30d:
+25.72%
90d:
+26.54%
WAIT
LOW Confidence
Analysis Updated: Jul 2, 2026 12:00 AM ET
Earnings: Apr 13, 2026
0d
Get Alerted When CANF Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR BETTER ENTRY: CANF is 11.7% above its trading range ($3.50). While momentum could continue, risk/reward favors waiting for a pullback.
⏸️ WAIT FOR BETTER ENTRY: CANF is 11.7% above its trading range ($3.50). While momentum could continue, risk/reward favors waiting for a pullback.
In-depth Analysis How we analyze
Valuation Analysis: CANF is currently trading at $3.91, which is considered extended relative to its 30-day fair value range of $2.78 to $3.50.
Technical Outlook: Technically, CANF is in a downtrend. Immediate support is located at $2.56, while resistance sits at $5.98. Short-term momentum is weak, with the stock down 15.6% recently.
Market Sentiment: CANF has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $5.00 (+27.9%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, CANF is in a downtrend. Immediate support is located at $2.56, while resistance sits at $5.98. Short-term momentum is weak, with the stock down 15.6% recently.
Market Sentiment: CANF has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $5.00 (+27.9%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$2.78 -
$3.50
Company Quality Score
54/100
(HOLD)
Volume Confirmation
MODERATE
Confidence Score
42.1%
All Signals
- BEARISH: Price significantly overextended (+11.7% above its trading range)
- BULLISH: Strong technical setup (60/100)
- BEARISH: Downward momentum (-15.6%)
- BULLISH: Trading 27.9% below Wall St target ($5.00)
Trading Range Analysis
30-Day Trading Range
$2.78 -
$3.50
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$2.56
Resistance Level
$5.98
Current Trend
Downtrend
Technical data as of
Jul 2, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-15.04
Wall Street Target
$5.00
(+27.9%)
Revenue Growth (YoY)
-43.3%
Share & Embed Analysis
Last updated: July 03, 2026 7:12 PM ET
Data refreshes hourly during market hours. Next update: 8:12 PM
Data refreshes hourly during market hours. Next update: 8:12 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is CANF showing a specific setup today?
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
VRTX
Vertex Pharmaceuticals I… |
BUY
34 analysts |
$549 | 59 HOLD |
|
CYTK
Cytokinetics Inc |
STRONG BUY
21 analysts |
$106 | 64 BUY |
|
XENE
Xenon Pharmaceuticals Inc |
STRONG BUY
19 analysts |
$81 | 54 HOLD |
|
MRUS
Merus BV |
STRONG BUY
17 analysts |
$97 | 55 HOLD |
|
MLTX
MoonLake Immunotherapeut… |
STRONG BUY
16 analysts |
$28 | 45 HOLD |
